查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1547598

全球無創產前檢測市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Noninvasive Prenatal Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 233 Pages | 商品交期: 最快1-2個工作天內

價格

全球非侵入性產前檢測市場需求預計將從 2023 年的 47.1 億美元達到近 49.6 億美元的市場規模，2024-2032 年研究期間複合年成長率為 0.58%。

非侵入性產前檢測 (NIPT) 是一種篩檢方法，用於識別發育中胎兒的遺傳異常，無需採取羊膜穿刺術或絨毛膜絨毛取樣等侵入性操作。 NIPT 分析母親血液中循環的胎兒遊離DNA，以評估染色體疾病的風險，包括愛德華茲症候群（18 三體）、唐氏症（21 三體症）和帕陶氏症候群（13 三體症）以及特定的性染色體異常。與傳統的產前檢測方法相比，NIPT 提供了更安全、更準確的選擇，通常可以在懷孕早期獲得結果。

市場動態

推動非侵入性產前檢測市場的因素包括對早期準確檢測胎兒異常的需求不斷成長、非侵入性產前篩檢測試的日益普及以及基因檢測技術的進步。隨著孕產婦年齡的增加和對產前篩檢選擇的認知不斷提高，對非侵入性產前檢測的需求不斷成長。此外，定序技術、生物資訊學和遺傳分析方法的技術進步推動了 NIPT 的創新，提高了檢測胎兒遺傳異常的準確性、敏感度和特異性。此外，NIPT 篩檢的遺傳性疾病範圍不斷擴大，包括微缺失和性染色體非整倍體，透過解決未滿足的臨床需求和改善患者護理，進一步刺激市場成長。此外，專業醫學會和監管機構對 NIPT 的認可以及醫療保健支付者的報銷範圍提高了孕婦對 NIPT 的可及性和採用率。然而，監管障礙和報銷挑戰可能會阻礙未來幾年無創產前檢測市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球無創產前檢測市場的各個細分市場進行了包容性評估。非侵入性產前檢測產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

非侵入性產前檢測市場報告的這一部分提供了有關國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按妊娠期

  • 0-12週
  • 13-24週
  • 25-36週

按懷孕風險

  • 高風險和中等風險
  • 低風險

依方法

  • 超音波檢測
  • 生化篩選試驗
  • 母體血漿檢測中的遊離 DNA

依技術

  • NGS
  • 陣列技術
  • 聚合酶鍊式反應
  • 其他

按產品分類

  • 耗材及試劑
  • 儀器儀表

按申請

  • 三體性
  • 微缺失症候群
  • 其他應用

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲無創產前檢測市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。非侵入性產前檢測市場的主要參與者包括 Genesis Genetics (CooperSurgical Inc.)、Natera Inc.、Centogene NV、Illumina Inc. (Verinata Health Inc.)、Eurofins LifeCodexx GmbH、MedGenome Labs Ltd.、F. Hoffmann-La Roche Ltd.、(Ariosa Diagnostics)、Myriad Women'S Health Inc. (Counsyl Inc.)、QIAGEN、Laboratory Corp. Of America Holdings、Progenity Inc.、Quest Diagnostics Inc. 本部分包含競爭格局的整體視圖，其中包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：非侵入性產前檢測 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按醞釀期間的市場吸引力分析
    • 以懷孕風險進行的市場吸引力分析
    • 市場吸引力分析方法
    • 按技術分類的市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 市場吸引力分析：依應用分類
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球非侵入性產前檢測市場分析：依妊娠期分類

  • 按妊娠期概述
  • 歷史和預測數據
  • 按妊娠分析
  • 0-12週
  • 13-24週
  • 25-36週

第 6 章：全球非侵入性產前檢測市場分析：依懷孕風險分類

  • 按懷孕風險概述
  • 歷史和預測數據
  • 按懷孕風險分析
  • 高風險和中等風險
  • 低風險

第 7 章：全球非侵入性產前檢測市場分析：依方法

  • 依方法概述
  • 歷史和預測數據
  • 方法分析
  • 超音波檢測
  • 生化篩選試驗
  • 母體血漿檢測中的遊離 DNA

第 8 章：全球非侵入性產前檢測市場分析：依技術分類

  • 依技術概述
  • 歷史和預測數據
  • 技術分析
  • NGS
  • 陣列技術
  • 聚合酶鍊式反應
  • 其他

第 9 章：全球無創產前檢測市場分析：按產品

  • 概述（按產品）
  • 歷史和預測數據
  • 按產品分析
  • 耗材及試劑
  • 儀器儀表

第 10 章：全球非侵入性產前檢測市場分析：按應用分類

  • 概述：按應用
  • 歷史和預測數據
  • 分析：按應用
  • 三體性
  • 微缺失症候群
  • 其他應用

第 11 章：全球無創產前檢測市場分析：按地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 12 章：非侵入性產前檢測公司的競爭格局

  • 非侵入性產前檢測市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 13 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Genesis Genetics (CooperSurgical Inc.)
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Natera Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Centogene NV
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Illumina Inc. (Verinata Health Inc.)
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Eurofins LifeCodexx GmbH
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • MedGenome Labs Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • F. Hoffmann-La Roche Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • (Ariosa Diagnostics)
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Myriad Women'S Health Inc. (Counsyl Inc.)
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • QIAGEN
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Laboratory Corp. Of America Holdings
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Progenity Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Quest Diagnostics Inc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR11214554

The global demand for Noninvasive Prenatal Testing Market is presumed to reach the market size of nearly USD 4.96 Billion by 2032 from USD 4.71 Billion in 2023 with a CAGR of 0.58% under the study period 2024-2032.

Noninvasive prenatal testing (NIPT) is a screening method used to identify genetic anomalies in a developing fetus without resorting to invasive procedures like amniocentesis or chorionic villus sampling. NIPT analyzes cell-free fetal DNA circulating in the mother's bloodstream to assess the risk of chromosomal disorders, including Edwards syndrome (trisomy 18), Down syndrome (trisomy 21), and Patau syndrome (trisomy 13), as well as specific sex chromosome abnormalities. NIPT offers a safer and more accurate option compared to traditional prenatal testing methods, with results typically available early in pregnancy.

MARKET DYNAMICS

The factors driving the noninvasive prenatal testing market include the spurring demand for early & accurate detection of fetal abnormalities, the growing adoption of noninvasive prenatal screening tests, and advancements in genetic testing technologies. With the rising maternal age and the increasing awareness of prenatal screening options, there is a growing demand for noninvasive prenatal testing. Additionally, technological advancements in sequencing technologies, bioinformatics, and genetic analysis methods drive innovation in NIPT, offering improved accuracy, sensitivity, and specificity in detecting fetal genetic abnormalities. Moreover, the expanding range of genetic conditions screened by NIPT, including microdeletions and sex chromosome aneuploidies, further stimulates market growth by addressing unmet clinical needs and improving patient care. Furthermore, the endorsement of NIPT by professional medical societies and regulatory agencies and reimbursement coverage by healthcare payers enhances accessibility and adoption of NIPT among pregnant women. However, regulatory hurdles and reimbursement challenges may hinder the growth of the noninvasive prenatal testing market in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Noninvasive Prenatal Testing. The growth and trends of Noninvasive Prenatal Testing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Noninvasive Prenatal Testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Gestation Period

  • 0-12 Weeks
  • 13-24 Weeks
  • 25-36 Weeks

By Pregnancy Risk

  • High & Average Risk
  • Low Risk

By Method

  • Ultrasound Detection
  • Biochemical Screening Tests
  • Cell-free DNA in Maternal Plasma Tests

By Technology

  • NGS
  • Array Technology
  • PCR
  • Others

By Product

  • Consumables & Reagents
  • Instruments

By Application

  • Trisomy
  • Microdeletion Syndrome
  • Other Applications

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Noninvasive Prenatal Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Noninvasive Prenatal Testing market include Genesis Genetics (CooperSurgical Inc.), Natera Inc., Centogene N.V., Illumina Inc. (Verinata Health Inc.), Eurofins LifeCodexx GmbH, MedGenome Labs Ltd., F. Hoffmann-La Roche Ltd., (Ariosa Diagnostics), Myriad Women'S Health Inc. (Counsyl Inc.), QIAGEN, Laboratory Corp. Of America Holdings, Progenity Inc., Quest Diagnostics Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. NONINVASIVE PRENATAL TESTING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Gestation Period
    • 3.7.2 Market Attractiveness Analysis By Pregnancy Risk
    • 3.7.3 Market Attractiveness Analysis By Method
    • 3.7.4 Market Attractiveness Analysis By Technology
    • 3.7.5 Market Attractiveness Analysis By Product
    • 3.7.6 Market Attractiveness Analysis By Application
    • 3.7.7 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL NONINVASIVE PRENATAL TESTING MARKET ANALYSIS BY GESTATION PERIOD

  • 5.1. Overview By Gestation Period
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Gestation Period
  • 5.4. 0-12 Weeks Historic and Forecast Sales By Regions
  • 5.5. 13-24 Weeks Historic and Forecast Sales By Regions
  • 5.6. 25-36 Weeks Historic and Forecast Sales By Regions

6. GLOBAL NONINVASIVE PRENATAL TESTING MARKET ANALYSIS BY PREGNANCY RISK

  • 6.1. Overview By Pregnancy Risk
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Pregnancy Risk
  • 6.4. High & Average Risk Historic and Forecast Sales By Regions
  • 6.5. Low Risk Historic and Forecast Sales By Regions

7. GLOBAL NONINVASIVE PRENATAL TESTING MARKET ANALYSIS BY METHOD

  • 7.1. Overview By Method
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Method
  • 7.4. Ultrasound Detection Historic and Forecast Sales By Regions
  • 7.5. Biochemical Screening Tests Historic and Forecast Sales By Regions
  • 7.6. Cell-free DNA in Maternal Plasma Tests Historic and Forecast Sales By Regions

8. GLOBAL NONINVASIVE PRENATAL TESTING MARKET ANALYSIS BY TECHNOLOGY

  • 8.1. Overview By Technology
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By Technology
  • 8.4. NGS Historic and Forecast Sales By Regions
  • 8.5. Array Technology Historic and Forecast Sales By Regions
  • 8.6. PCR Historic and Forecast Sales By Regions
  • 8.7. Others Historic and Forecast Sales By Regions

9. GLOBAL NONINVASIVE PRENATAL TESTING MARKET ANALYSIS BY PRODUCT

  • 9.1. Overview By Product
  • 9.2. Historical and Forecast Data
  • 9.3. Analysis By Product
  • 9.4. Consumables & Reagents Historic and Forecast Sales By Regions
  • 9.5. Instruments Historic and Forecast Sales By Regions

10. GLOBAL NONINVASIVE PRENATAL TESTING MARKET ANALYSIS BY APPLICATION

  • 10.1. Overview By Application
  • 10.2. Historical and Forecast Data
  • 10.3. Analysis By Application
  • 10.4. Trisomy Historic and Forecast Sales By Regions
  • 10.5. Microdeletion Syndrome Historic and Forecast Sales By Regions
  • 10.6. Other Applications Historic and Forecast Sales By Regions

11. GLOBAL NONINVASIVE PRENATAL TESTING MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Regional Outlook
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.3.2 North America By Segment Sales Analysis
    • 11.3.3 North America By Country Sales Analysis
    • 11.3.4 United States Sales Analysis
    • 11.3.5 Canada Sales Analysis
    • 11.3.6 Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.4.2 Europe By Segment Sales Analysis
    • 11.4.3 Europe By Country Sales Analysis
    • 11.4.4 United Kingdom Sales Analysis
    • 11.4.5 France Sales Analysis
    • 11.4.6 Germany Sales Analysis
    • 11.4.7 Italy Sales Analysis
    • 11.4.8 Russia Sales Analysis
    • 11.4.9 Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.5.2 Asia Pacific By Segment Sales Analysis
    • 11.5.3 Asia Pacific By Country Sales Analysis
    • 11.5.4 China Sales Analysis
    • 11.5.5 India Sales Analysis
    • 11.5.6 Japan Sales Analysis
    • 11.5.7 South Korea Sales Analysis
    • 11.5.8 Australia Sales Analysis
    • 11.5.9 South East Asia Sales Analysis
    • 11.5.10 Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.6.2 Latin America By Segment Sales Analysis
    • 11.6.3 Latin America By Country Sales Analysis
    • 11.6.4 Brazil Sales Analysis
    • 11.6.5 Argentina Sales Analysis
    • 11.6.6 Peru Sales Analysis
    • 11.6.7 Chile Sales Analysis
    • 11.6.8 Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.7.2 Middle East & Africa By Segment Sales Analysis
    • 11.7.3 Middle East & Africa By Country Sales Analysis
    • 11.7.4 Saudi Arabia Sales Analysis
    • 11.7.5 UAE Sales Analysis
    • 11.7.6 Israel Sales Analysis
    • 11.7.7 South Africa Sales Analysis
    • 11.7.8 Rest Of Middle East And Africa Sales Analysis

12. COMPETITIVE LANDSCAPE OF THE NONINVASIVE PRENATAL TESTING COMPANIES

  • 12.1. Noninvasive Prenatal Testing Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13. COMPANY PROFILES OF NONINVASIVE PRENATAL TESTING INDUSTRY

  • 13.1. Top Companies Market Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. Genesis Genetics (CooperSurgical Inc.)
    • 13.3.1 Company Overview
    • 13.3.2 Company Revenue
    • 13.3.3 Products
    • 13.3.4 Recent Developments
  • 13.4. Natera Inc.
    • 13.4.1 Company Overview
    • 13.4.2 Company Revenue
    • 13.4.3 Products
    • 13.4.4 Recent Developments
  • 13.5. Centogene N.V.
    • 13.5.1 Company Overview
    • 13.5.2 Company Revenue
    • 13.5.3 Products
    • 13.5.4 Recent Developments
  • 13.6. Illumina Inc. (Verinata Health Inc.)
    • 13.6.1 Company Overview
    • 13.6.2 Company Revenue
    • 13.6.3 Products
    • 13.6.4 Recent Developments
  • 13.7. Eurofins LifeCodexx GmbH
    • 13.7.1 Company Overview
    • 13.7.2 Company Revenue
    • 13.7.3 Products
    • 13.7.4 Recent Developments
  • 13.8. MedGenome Labs Ltd.
    • 13.8.1 Company Overview
    • 13.8.2 Company Revenue
    • 13.8.3 Products
    • 13.8.4 Recent Developments
  • 13.9. F. Hoffmann-La Roche Ltd.
    • 13.9.1 Company Overview
    • 13.9.2 Company Revenue
    • 13.9.3 Products
    • 13.9.4 Recent Developments
  • 13.10. (Ariosa Diagnostics)
    • 13.10.1 Company Overview
    • 13.10.2 Company Revenue
    • 13.10.3 Products
    • 13.10.4 Recent Developments
  • 13.11. Myriad Women'S Health Inc. (Counsyl Inc.)
    • 13.11.1 Company Overview
    • 13.11.2 Company Revenue
    • 13.11.3 Products
    • 13.11.4 Recent Developments
  • 13.12. QIAGEN
    • 13.12.1 Company Overview
    • 13.12.2 Company Revenue
    • 13.12.3 Products
    • 13.12.4 Recent Developments
  • 13.13. Laboratory Corp. Of America Holdings
    • 13.13.1 Company Overview
    • 13.13.2 Company Revenue
    • 13.13.3 Products
    • 13.13.4 Recent Developments
  • 13.14. Progenity Inc.
    • 13.14.1 Company Overview
    • 13.14.2 Company Revenue
    • 13.14.3 Products
    • 13.14.4 Recent Developments
  • 13.15. Quest Diagnostics Inc
    • 13.15.1 Company Overview
    • 13.15.2 Company Revenue
    • 13.15.3 Products
    • 13.15.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Gestation Period (USD MN)
  • 0-12 Weeks Market Sales By Geography (USD MN)
  • 13-24 Weeks Market Sales By Geography (USD MN)
  • 25-36 Weeks Market Sales By Geography (USD MN)
  • Analysis By Pregnancy Risk (USD MN)
  • High & Average Risk Market Sales By Geography (USD MN)
  • Low Risk Market Sales By Geography (USD MN)
  • Analysis By Method (USD MN)
  • Ultrasound Detection Market Sales By Geography (USD MN)
  • Biochemical Screening Tests Market Sales By Geography (USD MN)
  • Cell-free DNA in Maternal Plasma Tests Market Sales By Geography (USD MN)
  • Analysis By Technology (USD MN)
  • NGS Market Sales By Geography (USD MN)
  • Array Technology Market Sales By Geography (USD MN)
  • PCR Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Product (USD MN)
  • Consumables & Reagents Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Trisomy Market Sales By Geography (USD MN)
  • Microdeletion Syndrome Market Sales By Geography (USD MN)
  • Other Applications Market Sales By Geography (USD MN)
  • Global Noninvasive Prenatal Testing Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Noninvasive Prenatal Testing Report
  • Market Research Process
  • Market Research Methodology
  • Global Noninvasive Prenatal Testing Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Gestation Period
  • Market Attractiveness Analysis By Pregnancy Risk
  • Market Attractiveness Analysis By Method
  • Market Attractiveness Analysis By Technology
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Gestation Period (USD MN)
  • 0-12 Weeks Market Sales By Geography (USD MN)
  • 13-24 Weeks Market Sales By Geography (USD MN)
  • 25-36 Weeks Market Sales By Geography (USD MN)
  • Global Market Analysis By Pregnancy Risk (USD MN)
  • High & Average Risk Market Sales By Geography (USD MN)
  • Low Risk Market Sales By Geography (USD MN)
  • Global Market Analysis By Method (USD MN)
  • Ultrasound Detection Market Sales By Geography (USD MN)
  • Biochemical Screening Tests Market Sales By Geography (USD MN)
  • Cell-free DNA in Maternal Plasma Tests Market Sales By Geography (USD MN)
  • Global Market Analysis By Technology (USD MN)
  • NGS Market Sales By Geography (USD MN)
  • Array Technology Market Sales By Geography (USD MN)
  • PCR Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Product (USD MN)
  • Consumables & Reagents Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Trisomy Market Sales By Geography (USD MN)
  • Microdeletion Syndrome Market Sales By Geography (USD MN)
  • Other Applications Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.